Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA RECALLS & COURT ACTIONS: June 9, 1993

Executive Summary

CLASS II - DOXEPIN HYDROCHLORIDE CAPSULES, USP (a) 100 mg, in bottles of 100; (b) 150 mg, in bottles of 50, a Rx anti-depressant. Recall number: D-272/273-3. Control numbers: 346-154 EXP 11/94; 346-155 EXP 12/94. Manufacturer: Lederle Arzneimittel Cyanamid GmbH, Germany. Recalled by: Lederle Laboratories, Division of American Cyanamid Company, Pearl River, New York, by letter May 21, 1993. Firm-initiated recall ongoing. Distribution: Alabama, Arkansas, Colorado, Connecticut, Florida, Louisiana, Maine, Pennsylvania, Kentucky, New Jersey, Virginia, West Virginia, South Carolina, Tennessee, Texas; (a) 1,201 bottles; (b) 1,553 bottles were distributed. Reason: Products do not meet dissolution specifications. CLASS III CHLOROMYCETIN CREAM, 1% (CHLORAMPHENICOL CREAM, USP) In 1 ounce tubes, Rx topical used for the treatment of surface skin infections. Recall number: D-271-3. Lot number 00172B EXP 7/93. Manufacturer: Parke-Davis Canada, Inc., Ontario, Canada. Recalled by: Warner-Lambert Company, Parke-Davis Division, Morris Plains, New Jersey, by letter dated April 26, 1993. Firm-initiated recall ongoing. Distribution: Nationwide; 6,216 tubes were distributed; firm estimates 2,000 tubes remain on the market. Reason: Product does not meet specifications for the propylparaben ingredient.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS022775

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel